Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy

Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy

US Patent 12409230 · Granted Sep 9, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conj2025
Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conj2025
Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conj2025
Multivalent delivery of immune modulators by liposomal spherical nucleic acids f2024
Modulating angiogenesis by proteomimetics of vascular endothelial growth factor2024
Synthesis of spherical nucleic acids using lipophilic moieties2023
Multivalent delivery of immune modulators by liposomal spherical nucleic acids f2021
Spherical nucleic acid-based constructs as immunostimulatory agents for prophyla2021
Spherical nucleic acid-based constructs as immunostimulatory agents for prophyla2020
Multivalent delivery of immune modulators by liposomal spherical nucleic acids f2019